An outbreak of artemisinin resistant falciparum malaria in Eastern Thailand

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Imwong, Mallika ^a   Jindakhad, Thantip ^a   Kunasol, Chanon ^a   Sutawong, Kreepol ^b   Vejakama, Phisitt ^b   Dondorp, Arjen M ^a,c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Amphoe Buntharik   (Thailand)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; MICROSATELLITE DNA; PROTOZOAL PROTEIN;

ADOLESCENT; ADULT; CLASSIFICATION; CLUSTER ANALYSIS; DRUG EFFECTS; DRUG RESISTANCE; EPIDEMIC; FEMALE; GENE DOSAGE; GENETICS; GENOTYPE; HUMAN; MALARIA, FALCIPARUM; MALE; MOLECULAR TYPING; MUTATION; PARASITOLOGY; PHYLOGENY; PLASMODIUM FALCIPARUM; THAILAND; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIMALARIALS; ARTEMISININS; CLUSTER ANALYSIS; DISEASE OUTBREAKS; DRUG RESISTANCE; FEMALE; GENE DOSAGE; GENOTYPE; HUMANS; MALARIA, FALCIPARUM; MALE; MICROSATELLITE REPEATS; MOLECULAR TYPING; MUTATION; PHYLOGENY; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; THAILAND; YOUNG ADULT;

EID: 84948680422     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17412     Document Type: Article

References (34)

1. WHO. World Health Organization. World malaria report. (2014). Available at: http://www.who.int/malaria/publications/world- malaria-report-2014/report/en. (Accessed: 24th July 2015
2. White, N. J. Qinghaosu (artemisinin): the price of success. Science. 320, 330-334 (2008
3. Dondorp, A. M., et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 361, 455-467 (2009
4. Noedl, H., et al. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 359, 2619-2620 (2008
5. Phyo, A. P., et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 379, 1960-1966 (2012
6. Tun, K. M., et al. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. Lancet Infect Dis. 15, 415-421 (2015
7. Carrara, V. I., et al. Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study. PLoS Med. 10, e1001398 (2013
8. Lim, P., et al. Decreasing pfmdr1 copy number suggests that Plasmodium falciparum in Western Cambodia is regaining in vitro susceptibility to mefloquine. Antimicrob Agents Chemother. 59, 2934-2937 (2015
9. Spring, M. D., et al. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study. Lancet Infect Dis. 15, 683-691 (2015
10. WHO. Global Malaria Programme WHO. Status report on artemisinin resistance January 2014. (2015) Available at: http://www. who.int/malaria/publications/atoz/status-rep-artemisinin-resistance-jan2014.pdf. (Accessed: 24th July 2015
11. Bureau of Vector Born Disease (BVBD) of the Ministry of Public Health, K. o. T. (2015) Available at: http://www.thaivbd.org/n/ contents/view/324685. (Accessed: 24th July 2015
12. Ariey, F., et al A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 505, 50-55 (2014
13. Price, R. N., et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet. 364, 438-447 (2004
14. Peterson, D. S., Walliker, D., & Wellems, T. E. Evidence that a point mutation in dihydrofolate reductase-Thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc Natl Acad Sci USA. 85, 9114-9118 (1988
15. Fidock, D. A., et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell. 6, 861-871 (2000
16. Mobegi, V. A., et al. Population genetic structure of Plasmodium falciparum across a region of diverse endemicity in West Africa. Malar J. 11, 223 (2012
17. Straimer, J., et al. Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science. 347, 428-431 (2015
18. Miotto, O., et al. Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nat Genet. 47, 226-234 (2015
19. Ghorbal, M., et al. Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system. Nat Biotechnol. 32, 819-821 (2014
20. Imwong, M., et al. Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum. Antimicrob Agents Chemother. 54, 2886-2892 (2010
21. Humphreys, G. S., et al. Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria. Antimicrob Agents Chemother. 51, 991-997 (2007
22. Venkatesan, M., et al. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunateamodiaquine. Am J Trop Med Hyg. 91, 833-843 (2014
23. Takala-Harrison, S., et al. Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia. J Infect Dis. 211, 670-679 (2015
24. Dondorp, A. M., et al. Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol. 8, 272-280 (2010
25. Miotto, O., et al. Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat Genet. 45, 648-655 (2013
26. Anderson, T. J., et al. High heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in western Cambodia. J Infect Dis. 201, 1326-1330 (2010
27. Dondorp, A. M., et al. Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational crosssectional survey on the prevalence of fake antimalarials. Trop Med Int Health. 9, 1241-1246 (2004
28. Sengaloundeth, S., et al A stratified random survey of the proportion of poor quality oral artesunate sold at medicine outlets in the Lao PDR - implications for therapeutic failure and drug resistance. Malar J. 8, 172 (2009
29. Tabernero, P., et al A Repeat Random Survey of the Prevalence of Falsified and Substandard Antimalarials in the Lao PDR: A Change for the Better. Am J Trop Med Hyg. 92, 95-104 (2015
30. PATH. RBP-EIA: collecting, processing, and handling venous, capillary, and blood spot samples. (PATH, 2005
31. Duraisingh, M. T., et al. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol Biochem Parasitol. 108, 13-23 (2000
32. Duraisingh, M. T., Curtis, J., & Warhurst, D. C. Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. Exp Parasitol. 89, 1-8 (1998
33. WHO. Genotyping to identify parasite populations. (2008) Available at: http://apps.who.int/iris/bitstream/10665/43824/1/9789241596305- eng.pdf. (Accessed: 24th July 2015
34. Anderson, T. J., Su, X. Z., Bockarie, M., Lagog, M., & Day, K. P. Twelve microsatellite markers for characterization of Plasmodium falciparum from finger-prick blood samples. Parasitology 119(Pt 2), 113-125 (1999